IP Verse

Process For Culturing Mammalian Cells - EP3717656

The patent EP3717656 was granted to F Hoffmann LA Roche on Mar 13, 2024. The application was originally filed on Nov 29, 2018 under application number EP18811260A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3717656

F HOFFMANN LA ROCHE
Application Number
EP18811260A
Filing Date
Nov 29, 2018
Status
Granted And Under Opposition
Feb 9, 2024
Grant Date
Mar 13, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

OETKEDec 13, 2024OETKEADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP20170204794-
DESCRIPTIONUS2014051124
DESCRIPTIONUS8470552
DESCRIPTIONUS8765413
DESCRIPTIONWO2008033517
DESCRIPTIONWO2011070024
DESCRIPTIONWO2011117329
INTERNATIONAL-SEARCH-REPORTWO2012140171
INTERNATIONAL-SEARCH-REPORTWO2015128795
OPPOSITIONUS8765413
OPPOSITIONWO2018073365
OPPOSITIONWO2018170099

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- D1-PCT Direct Letter dated November 29, 2018 submitted when filing the application for the Opposed Patent-
OPPOSITION- D2-Priority application EP 17 204 794.6-
OPPOSITION- D4a- US 62471347_Priority document of WO 2018/170099 A1-
OPPOSITION- Rachel Legmann; H. Brett Schreyer; Rodney G. Combs; Ellen L. McCormick; A. Peter Russo; Seth T. Rodgers, "A predictive high‐throughput scale‐down model of monoclonal antibody production in CHO cells", Biotechnology and Bioengineering, Hoboken, USA, (20090721), vol. 104, no. 6, doi:10.1002/bit.22474, ISSN 0006-3592, pages 1107 - 1120, XP071108330
OPPOSITION- Matthew Gagnon; Gregory Hiller; Yen‐Tung Luan; Amy Kittredge; Jordy DeFelice; Denis Drapeau, "High-End pH-Controlled Delivery of Glucose Effectively Suppresses Lactate Accumulation in CHO Fed-Batch Cultures", Biotechnology and Bioengineering, Hoboken, USA, (20110224), vol. 108, no. 6, doi:10.1002/bit.23072, ISSN 0006-3592, pages 1328 - 1337, XP071098253
OPPOSITION- Satoshi Oguchi ; Hiroyuki Saito ; Masayoshi Tsukahara ; Haruhiko Tsumura, "pH Condition in temperature shift cultivation enhances cell longevity and specific hMab productivity in CHO culture", Cytotechnology, Do , (20070308), vol. 52, no. 3, doi:10.1007/s10616-007-9059-2, ISSN 1573-0778, pages 199 - 207, XP019499827
OPPOSITION- Hogiri Tomoharu, Tamashima Hiroshi, Nishizawa Akitoshi, Okamoto Masahiro, "Optimization of a pH-shift control strategy for producing monoclonal antibodies in Chinese hamster ovary cell cultures using a pH-dependent dynamic model", Journal of bioscience and bioengineering, NL , (20180201), vol. 125, no. 2, doi:10.1016/j.jbiosc.2017.08.015, ISSN 1389-1723, pages 245 - 250, XP093240528
OPPOSITION- Francesca Zagari, Jordan Martin, Stettler Matthieu, Broly Hervé, Wurm Florian M., "Lactate metabolism shift in CHO cell culture: the role of mitochondrial oxidative activity", New BIOTECHNOLOGY, NL , (20130101), vol. 30, no. 2, doi:10.1016/j.nbt.2012.05.021, ISSN 1871-6784, pages 238 - 245, XP055295213

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents